Cabot, Cabot & Forbes, a Greater Boston area real estate development, has filed plans for a 14-acre multi-building life sciences campus in Woburn, Mass.
The campus, 216 New Boston, will include a 175,000-square-foot multi-story lab and office building as well as a 135,000-square-foot purpose-built manufacturing facility intended for biomanufacturing and Current Good Manufacturing Practices (cGMP), a standard of pharmaceutical development that industry experts increasingly view as a growing need in the suburban life sciences market. Cushman & Wakefield represents the project for all life sciences tenant leasing.
216 New Boston will feature best-in-class research and manufacturing facilities for firms at all points in the pharmaceutical development pipeline, offering a similarly diverse array of jobs at a wide range of education levels and salary points. Unlike existing facilities in the area, 216 New Boston will feature efficient and flexible floorplans and high
